Guanfacine Tablet, Extended Release
Product Images NDC 70518-2771

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Guanfacine (NDC 70518-2771). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure-1.jpg (Figure 1)

FDA Label Image

Figure-2.jpg (Figure 2)

FDA Label Image

Figure-3.jpg (Figure 3)

FDA Label Image

Figure-4.jpg (Figure 4)

FDA Label Image

Guanfacine 1mg 70518 2771 00

Guanfacine 1mg 70518 2771 00
This is a description of the medication "guanFACINE" which comes in the form of extended-release tablets of 1mg. These tablets are manufactured by TWI Pharmaceuticals USA and are available in a pack of 30 units. The medication should not be crushed, chewed, or broken before swallowing. The package insert contains instructions for use. The tablets must be kept out of the reach of children and stored at a temperature between 20-26°C (63-77°F). The medication is only available with a prescription. The text includes information about the NDC number, the manufacturer's information, lot number, and expiration date.*
FDA Label Image

Molecular-structure.jpg (Molecular Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.